Executive Director of Chinese Society of Immunology
Chairman of Jiangsu Immunization Society
Standing Committee of Microbiology and Immunology of Chinese Medical Association
Chairman of Jiangsu Branch of Microbiology and Immunology of Chinese Medical Association
In recent years, the director of Suzhou Anti-aging Society won the first prize 1 item, four second prizes and seven third prizes at the provincial and ministerial level, and the role of IL-6 signal in radiation protection and hematopoietic regulation and the development of its detection kit won the second prize of the Science, Technology and Industry Committee for National Defense in 2000. The expression and function of surface membrane molecules of human B-cell malignant tumor, the influence and significance on tumor biological behavior, and the development and application of human recombinant IL-8 and monoclonal antibody won the second prize in 2000 and 200 1 Jiangsu Province respectively. In recent years, he has published more than 40 papers1at home and abroad in the name of a correspondent. In 2000 and 20001year, 43 papers and 30 papers were published respectively, of which 8 papers were included in SCI. The graduate students won the first prize of 200 1 National Challenge Cup for College Students, and three graduate students won the National Tan Jiuyuan Lifetime Award, and won the title of Excellent Doctoral Supervisor in Jiangsu Province in 2000.
Patent serial number, release time, name, inventor's invention patent or
Certificate-level preparation and application of new drugs 1 2008 monoclonal antibody against human GL50 (ZL2005 100, 38732.0) Zhang Xueguang and other invention patents ranked first 2 2008 monoclonal antibody against human CD 154 and its application (ZL2005 100, 3873 1.6) Zhang Xueguang and other invention patents rank first 3 2000x) Zhang Xueguang and other invention patents rank first 5 2005 Preparation and application of anti-human OX40L monoclonal antibody (ZL 20010038729.9) Zhang Xueguang and other invention patents rank first 6 2005 anti-human CD40 mutant molecular monoclonal antibody and its application (.
Study on immunopathology and biological regulatory factors of human multiple myeloma The first prize of scientific and technological progress of the State Education Commission (ranked first) 1994.
Study on immunopathology and biological regulatory factors of B-cell proliferative diseases Second Prize of Jiangsu Science and Technology Progress (ranked first) 1995.
The role of IL-6 signal in radiation protection and hematopoietic regulation and the development of its detection reagent: the second prize of scientific and technological progress of the Commission of Science, Technology and Industry for National Defense in 2000 (ranked first).
The expression and function of cell membrane molecules in human B cell malignant tumor, and its influence and significance on the biological behavior of tumor cells; In 2000, Jiangsu Province won the second prize for scientific and technological progress (ranking first).
Development and application of recombinant human IL-8 and its monoclonal antibody: the second prize of Jiangsu Science and Technology Progress Award (ranking first) 200 1 year.
RhD blood group identification reagent (monoclonal antibody IgM) won the second prize of Suzhou science and technology progress in 2005 (ranked first)
Study on Immune Pathogenesis of Aplastic Anemia The Third Prize of Jiangsu Science and Technology Progress in 2007 (ranked first)
Clinical and Basic Research of Non-immune Nephropathy: Third Prize of Jiangsu Science and Technology Progress in 2008 (ranked second)
Immunomodulatory effect of costimulatory molecule B7H3 and its clinical application First prize of Jiangsu Medical Science and Technology Award (ranking first) 20 10 years
The role of macrophage proinflammatory factor and chemokine signal in neovascular ophthalmopathy: the second prize of Jiangsu Medical Science and Technology Award (ranked second) 20 10.
The application of soluble human B7-H3 in the diagnosis of non-small cell lung cancer: the first prize of Jiangsu Provincial Health Department's new medical technology introduction award (ranked first) 20 10 year.
Immunomodulatory effect of costimulatory molecule B7-H3 and its clinical application The second prize of Suzhou Science and Technology Progress (ranked first) 20 10
The role of macrophage proinflammatory factor and chemokine signal in neovascular ophthalmopathy: the third prize of Suzhou Science and Technology Progress Award (ranking first) 20 1 1 year.